HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 78 filers reported holding HARROW HEALTH INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,308 | -79.9% | 787 | -73.4% | 0.00% | – |
| Q2 2023 | $56,392 | -96.0% | 2,962 | -95.5% | 0.00% | -100.0% |
| Q1 2023 | $1,399,006 | +210.6% | 66,112 | +116.5% | 0.00% | +200.0% |
| Q4 2022 | $450,472 | +32.5% | 30,542 | +8.4% | 0.00% | 0.0% |
| Q3 2022 | $340,000 | +65.9% | 28,182 | 0.0% | 0.00% | – |
| Q2 2022 | $205,000 | -82.6% | 28,182 | +17850.3% | 0.00% | -100.0% |
| Q1 2022 | $1,176,000 | +39100.0% | 157 | -49.5% | 0.00% | – |
| Q4 2021 | $3,000 | -93.5% | 311 | -93.8% | 0.00% | – |
| Q3 2021 | $46,000 | -56.2% | 5,039 | -55.5% | 0.00% | – |
| Q2 2021 | $105,000 | +101.9% | 11,311 | +48.0% | 0.00% | – |
| Q1 2021 | $52,000 | +2.0% | 7,645 | +3.2% | 0.00% | – |
| Q4 2020 | $51,000 | +24.4% | 7,407 | -0.2% | 0.00% | – |
| Q3 2020 | $41,000 | -4.7% | 7,422 | -8.5% | 0.00% | – |
| Q2 2020 | $43,000 | +19.4% | 8,115 | -8.1% | 0.00% | – |
| Q1 2020 | $36,000 | – | 8,833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,795,000 | $54,534,150 | 17.74% |
| Private Capital Management, LLC | 1,416,900 | $20,360,853 | 2.41% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 91,779 | $1,318,864 | 1.86% |
| Birchview Capital, LP | 150,000 | $2,155,500 | 1.84% |
| Diametric Capital, LP | 286,127 | $4,111,644 | 1.72% |
| Ophir Asset Management Pty Ltd | 492,179 | $7,072,612 | 1.67% |
| BRAIDWELL LP | 1,808,684 | $25,990,789 | 0.82% |
| Westside Investment Management, Inc. | 159,019 | $2,285,117 | 0.66% |
| INVICTUS PRIVATE WEALTH, LLC | 400,066 | $5,748,948 | 0.63% |
| Portolan Capital Management | 385,964 | $5,546,303 | 0.52% |